This consequently resulted in promoting the proliferative, migrative, and invasive abilities of thyroid cancer cells in vitro, and augmenting the tumorigenesis in vivo via activating epidermal growth factor receptor (EGFR)/PI3K/Akt pathway [114]. Here, AKT1 is linked to thyroid cancer.